Oct 26, 4:11 PM ET
RadNet agreed on October 26, 2026 to acquire ONRAD, Inc., a teleradiology and in-hospital radiology staffing provider, for $350 million in cash and 5 million RadNet shares, subject to customary adjustments, plus an earnout of up to $210 million tied to ONRAD's 2027 Adjusted EBITDA. RadNet says ONRAD would add $190 million to $200 million of revenue and $60 million to $65 million of Adjusted EBITDA in its first year after closing, but the deal adds cash outflow and share issuance, and closing is expected in early 2027.
- Upfront consideration of $350 million in cash and 5,000,000 shares of RadNet common stock, subject to customary adjustments and escrow holdbacks
- Earnout of up to $210 million if ONRAD meets a target Post-Closing Annual Adjusted EBITDA for the fiscal year ending December 31, 2027, payable in cash, shares or both
- RadNet expects ONRAD to add $190 million to $200 million of revenue and $60 million to $65 million of Adjusted EBITDA in its first year after closing
- Closing expected in early 2027; the Hart-Scott-Rodino waiting period has expired, and a conference call is set for 8:00 a.m. Eastern Time on October 27, 2026
Read the filing on SEC.gov ↗
Aug 10, 6:07 AM ET
RadNet reported second-quarter 2026 revenue of $622.7 million, up 25.0%, and Adjusted EBITDA of $99.7 million, up 22.7%, both described as quarterly records. The company raised its 2026 Imaging Center guidance for revenue, Adjusted EBITDA and free cash flow, but GAAP net income attributable to RadNet fell to $7.5 million ($0.10 per diluted share) from $14.5 million ($0.19) a year earlier.
- Total Company Revenue rose 25.0% to $622.7 million and Adjusted EBITDA rose 22.7% to $99.7 million versus Q2 2025.
- Net income attributable to RadNet was $7.5 million, or $0.10 per diluted share, compared with $14.5 million, or $0.19, in Q2 2025.
- Adjusted EPS was $0.29 versus $0.34 in Q2 2025, after one-time items including $6.6 million of acquisition transaction costs and a $3.4 million debt restructuring loss.
- 2026 Imaging Center guidance raised to revenue of $2,370-$2,420 million and Adjusted EBITDA of $345-$358 million; Digital Health guidance reaffirmed.
Read the filing on SEC.gov ↗
Jun 10, 5:23 PM ET
RadNet entered into an amendment to its credit agreement that adds a $250.0 million incremental term loan, maturing April 18, 2031, and lowers the interest rate on its term loan and $282 million revolving credit facility by 0.25%. The company plans to use the proceeds for acquisitions, organic expansion, health system partnerships and general corporate purposes, while quarterly principal payments rise to approximately $3.1 million from approximately $2.4 million.
- $250.0 million incremental term loan added to the existing term loan, maturing April 18, 2031
- Term loan rate reduced 0.25% to Term SOFR plus 2.00% or Alternate Base Rate plus 1.00%, at the company's election
- Quarterly principal payments rise to approximately $3.1 million from approximately $2.4 million
- Revolving credit facility of $282 million, currently undrawn, had its rate reduced 0.25%
Read the filing on SEC.gov ↗
May 11, 7:24 AM ET
RadNet reported first-quarter 2026 revenue of $575.6 million, up 22.1% from a year earlier, and Adjusted EBITDA of $63.3 million, up 36.3%. The company still posted a net loss attributable to RadNet common stockholders of $33.5 million, or $(0.43) per share, narrowed from a $37.9 million loss, or $(0.51) per share, a year earlier. It raised 2026 Imaging Center guidance for revenue, Adjusted EBITDA and free cash flow and reaffirmed Digital Health guidance.
- Total Company revenue was $575.6 million, up $104.2 million from $471.4 million in Q1 2025.
- Imaging Center revised 2026 revenue guidance to $2,355 million to $2,405 million, from $2,325 million to $2,375 million.
- Imaging Center revised 2026 Adjusted EBITDA guidance to $340 million to $353 million, from $335 million to $348 million; free cash flow guidance rose to $112 million to $122 million, from $105 million to $115 million.
- Digital Health revenue rose 51.5% to $29.1 million, while its Adjusted EBITDA fell to $1.3 million from $3.7 million; Digital Health guidance was reaffirmed.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
